Shares of biotechnology company Moderna Inc. experienced a rare rally on Tuesday, with investors enjoying their first gain in two weeks. This positive movement came after the company announced that the first participant had been dosed in a Phase 3 trial of its combination vaccine candidate against the flu and COVID-19 in the U.S. Adding to the optimistic sentiment, ARK Genomic … [Read more...] about Moderna Inc. Sees Stock Rally as Phase 3 Trial Begins
Footer
